Insider · CIK 0001909680

Barone Francesca

Reports to the SEC for 1 company · NEEDHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001909680

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-29	CADLCandel Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−23.4K sh	$10.06	−$236K	77,362
2026-01-26	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+232K sh	—	—	232,000
2025-06-25	CADLCandel Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+4,282 sh	$4.67	+$20K	100,809
2025-03-18	CADLCandel Therapeutics, Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+18K sh	$1.55	+$27.9K	128,673
2025-03-18	CADLCandel Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−32.1K sh	$8.76	−$282K	96,527
2025-03-18	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−18K sh	—	—	30,822
2025-02-12	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+115K sh	—	—	115,000
2025-01-15	CADLCandel Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−13.5K sh	$7.22	−$97.8K	110,673
2025-01-08	CADLCandel Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−13.7K sh	$8.22	−$112K	124,207
2024-11-29	CADLCandel Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−22.1K sh	$4.56	−$101K	137,880
2024-07-17	CADLCandel Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−14.1K sh	$6.47	−$90.9K	159,961
2024-07-11	CADLCandel Therapeutics, Inc.S Sale	Chief Scientific Officer	SSale	−12.6K sh	$5.97	−$75.5K	174,012
2023-11-28	CADLCandel Therapeutics, Inc.F Tax Payment	Chief Scientific Officer	FTax Payment	−19.7K sh	$0.90	−$17.8K	186,657
2023-11-26	CADLCandel Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+113K sh	—	—	206,405
2023-04-28	CADLCandel Therapeutics, Inc. · Stock Option (Right to Biuy)A Award	Chief Scientific Officer	AAward	+90K sh	—	—	90,000
2022-12-08	CADLCandel Therapeutics, Inc.P Purchase	Chief Scientific Officer	PPurchase	+1,238 sh	$1.61	+$1,993.18	2,738
2022-11-28	CADLCandel Therapeutics, Inc.A Award	Chief Scientific Officer	AAward	+90.9K sh	—	—	92,377
2022-02-28	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+110K sh	—	—	110,000
2022-02-03	CADLCandel Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Chief Scientific Officer	AAward	+40K sh	—	—	40,000

Recent filings

Accepted (ET)
Jul 14
Barone Francesca0001909680-26-000002
SEC(opens sec.gov)
Jan 284
Barone Francesca0001193125-26-027392
SEC(opens sec.gov)
Jun 264
Barone Francesca0000950170-25-090194
SEC(opens sec.gov)
Mar 204
Barone Francesca0000950170-25-042726
SEC(opens sec.gov)
Feb 144
Barone Francesca0000950170-25-021282
SEC(opens sec.gov)
Jan 174
Barone Francesca0000950170-25-006726
SEC(opens sec.gov)
Jan 104
Barone Francesca0000950170-25-004200
SEC(opens sec.gov)
Dec 34
Barone Francesca0000950170-24-132925
SEC(opens sec.gov)
Jul 194
Barone Francesca0000950170-24-084758
SEC(opens sec.gov)
Jul 154
Barone Francesca0000950170-24-083396
SEC(opens sec.gov)
Nov 304
Barone Francesca0001209191-23-056982
SEC(opens sec.gov)
Nov 284
Barone Francesca0001209191-23-056806
SEC(opens sec.gov)
May 24
Barone Francesca0001209191-23-026549
SEC(opens sec.gov)
Dec 124
Barone Francesca0001209191-22-060700
SEC(opens sec.gov)
Nov 304
Barone Francesca0000899243-22-037230
SEC(opens sec.gov)
Mar 14
Barone Francesca0000899243-22-008370
SEC(opens sec.gov)
Feb 74
Barone Francesca0000899243-22-005079
SEC(opens sec.gov)

Companies

Candel Therapeutics, Inc.Chief Scientific OfficerCADL

Address

C/O CANDEL THERAPEUTICS, INC. 117 KENDRICK ST., SUITE 450

NEEDHAM, MA, 02494